Journal Flyer

Advances in Cancer Research & Clinical Imaging - ACRCI

ISSN: 2688-8203

Managing Editor: Julia Vinscent

Contact us at:

Open Access Mini Review

Genetic Screening Offers New Hope for Prostate Cancer Patients

Kathryn Leake*

Oncology Solutions, USA

Corresponding Author

Received Date: July 10, 2019;  Published Date: July 16, 2019


Abstract

The good news for prostate cancer patients currently undergoing chemotherapy treatments is that, genetic markers which once seemed the kiss of death may now permit classification into a group of new prostate cancer treatments! Hospitals should be made aware that if their prostate cancer patients are PTEN or p53 mutant, these patients may benefit from therapy blocking interleukin-6 (IL6)[1].

Article Details
Citation

  • Kathryn Leake. Genetic Screening Offers New Hope for Prostate Cancer Patients. Adv Can Res & Clinical Imag. 2(1): 2019. ACRCI.MS.ID.000528.

Signup for Newsletter
  • newsletter-subscription
© 2018 Iris Publishers LLC, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use. Creative Commons License Open Access by
Iris Publishers LLC is licensed under Creative Commons License a Creative Commons Attribution 4.0 International License. Based on a work at www.irispublishers.com. Best viewed in browser_icons browser_icons | Above IE 9.0 version | Privacy Policy
Scroll to Top